EMD-14475
AMC009 SOSIPv5.2 + ACS101 Fab
EMD-14475
Single-particle25.0 Å
Deposition: 02/03/2022Map released: 10/08/2022
Last modified: 17/08/2022
Sample Organism:
Homo sapiens
Sample: AMC009 SOSIPv5.2 in complex with ACS101 Fab
Deposition Authors: van Schooten J
,
Ward A
Sample: AMC009 SOSIPv5.2 in complex with ACS101 Fab
Deposition Authors: van Schooten J
,
Ward A
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein.
van Schooten J ,
Farokhi E ,
Schorcht A ,
van den Kerkhof TLGM,
Gao H,
van der Woude P,
Burger JA,
Meesters TGR ,
Bijl T,
Ghalaiyini R,
Turner HL,
Dorning J,
van Schaik BDC,
van Kampen AHC,
Labranche CC,
Stanfield RL ,
Sok D,
Montefiori DC ,
Burton DR ,
Seaman MS,
Ozorowski G ,
Wilson IA ,
Sanders RW ,
Ward AB ,
van Gils MJ
(2022) Nat Commun , 13 , 4515 - 4515
,
Farokhi E ,
Schorcht A ,
van den Kerkhof TLGM,
Gao H,
van der Woude P,
Burger JA,
Meesters TGR ,
Bijl T,
Ghalaiyini R,
Turner HL,
Dorning J,
van Schaik BDC,
van Kampen AHC,
Labranche CC,
Stanfield RL ,
Sok D,
Montefiori DC ,
Burton DR ,
Seaman MS,
Ozorowski G ,
Wilson IA ,
Sanders RW ,
Ward AB ,
van Gils MJ
(2022) Nat Commun , 13 , 4515 - 4515
Grant Support:
- Bill & Melinda Gates Foundation: OPP1115782 (United States)
- Bill & Melinda Gates Foundation: INV-002916 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI110657 (United States)